Please try another search
Polimex-Mostostal S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was PLN 3,013.63 million compared to PLN 3,784.2 million a year ago. Net loss was PLN 123.21 million compared to net income of PLN 132.41 million a year ago. Basic loss per share from continuing operations was PLN 0.511 compared to basic earnings per share from continuing operations of PLN 0.555 a year ago. Diluted loss per share from continuing operations was PLN 0.41 compared to diluted earnings per share from continuing operations of PLN 0.515 a year ago.
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Total Revenue | 745.51 | 825.47 | 911.48 | |
Gross Profit | -177.23 | 43.67 | 58.48 | 76.3 |
Operating Income | -226.84 | 24.28 | 28.99 | 27.34 |
Net Income | 19.53 | 22.91 | 13.12 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Total Assets | 2338.98 | 2437.17 | 2728.73 | |
Total Liabilities | 1244.67 | 1375.2 | 1691.16 | |
Total Equity | 1094.31 | 1061.97 | 1037.57 |
Period Ending: | Dec 31, 2023 | Sep 30, 2023 | Mar 31, 2023 | Dec 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -445.54 | 227.32 | ||
Cash From Investing Activities | -4.52 | 6.52 | ||
Cash From Financing Activities | -20.23 | -8.4 | ||
Net Change in Cash | -470.29 | 225.43 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review